Chief Medical Officer

Chief Medical Officer (CMO) Asia Pacific (APAC)

Compensation: Equity only
Reports to: Chief Executive Officer (CEO)
Scope: Asia-Pacific region only
Role Overview
The Chief Medical Officer Asia Pacific will lead the medical, clinical, and regulatory strategy exclusively across the Asia-Pacific region.
This role does not include responsibility for the United States, Europe, or other global markets.
The CMO will focus on establishing clinical validation, hospital partnerships, and regulatory pathways for the company's rehabilitation technology across Asia healthcare systems.
Primary markets include:

Taiwan
China
India
Japan
South Korea
Australia
Singapore
Southeast Asia (Thailand, Malaysia, Indonesia, Vietnam)
Compensation
Compensation for this role is equity-based.
Equity will be granted as stock options or founder-level equity participation, subject to a standard 4-year vesting schedule with a 1-year cliff.
The equity package reflects:
strategic leadership responsibilities
regional medical oversight across Asia-Pacific
clinical trial development and hospital adoption
regulatory approvals across multiple Asian markets
No salary is included at the initial stage.
Key Responsibilities
Clinical Programs (Asia-Pacific)
Lead and oversee clinical studies in Asia hospitals
Develop rehabilitation therapy protocols
Coordinate multi-country clinical trials
Hospital Partnerships
Develop relationships with:
rehabilitation hospitals
neurological recovery centers
spinal cord injury clinics
sports medicine institutions
across Asia-Pacific healthcare systems.
Regulatory Strategy
Lead medical regulatory pathways with authorities including:
Singapore
Health Sciences Authority (HSA)
Taiwan
Taiwan Food and Drug Administration (TFDA)
China
National Medical Products Administration (NMPA)
India
Central Drugs Standard Control Organization (CDSCO)
Japan
Pharmaceuticals and Medical Devices Agency (PMDA)
South Korea
Ministry of Food and Drug Safety (MFDS)
Australia
Therapeutic Goods Administration (TGA)
Medical Research
Lead peer-reviewed publications
Present research at Asia-Pacific medical conferences
Develop collaborations with academic hospitals
Reimbursement Strategy
Support development of reimbursement models across:
Singapore healthcare system
Taiwan National Health Insurance
China provincial reimbursement systems
Japan reimbursement pathways
hospital-based rehabilitation billing in India
Qualifications
MD or MD/PhD
1020+ years clinical experience
Background in:
rehabilitation medicine
neurology
orthopedics
Experience with clinical trials and regulatory approvals in Asia
Strategic Objective
The CMO Asia will build a clinically validated rehabilitation platform across Asia-Pacific healthcare systems, enabling hospital adoption and regulatory expansion throughout the region.